Furthermore, as described in detail previously [18], CXCR2 positive ovarian cancer cells enhanced more the promoter activity and mRNA levels of CXCL1 and 2 by NF-κB potentiation through EGFR-activated Akt compared to CXCR2 negative cells. This evidence concerns the gene AKT1 and ovarian cancer.